Put Options

11 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$22.17 - $51.8 $1.71 Million - $3.99 Million
77,000 Added 133.91%
134,500 $6.95 Million
Q2 2022

Aug 15, 2022

SELL
$15.36 - $27.51 $3.19 Million - $5.71 Million
-207,500 Reduced 78.3%
57,500 $1.43 Million
Q1 2022

May 13, 2022

BUY
$22.22 - $39.12 $2.76 Million - $4.87 Million
124,400 Added 88.48%
265,000 $6.64 Million
Q4 2021

Feb 11, 2022

SELL
$18.38 - $40.5 $9.75 Million - $21.5 Million
-530,500 Reduced 79.05%
140,600 $5.12 Million
Q3 2021

Nov 12, 2021

BUY
$13.18 - $19.83 $3.57 Million - $5.38 Million
271,100 Added 67.77%
671,100 $11.5 Million
Q2 2021

Aug 16, 2021

BUY
$9.59 - $50.88 $3.4 Million - $18.1 Million
355,000 Added 788.89%
400,000 $5.36 Million
Q1 2021

May 17, 2021

BUY
$49.53 - $68.4 $2.23 Million - $3.08 Million
45,000 New
45,000 $2.31 Million
Q4 2020

Feb 16, 2021

SELL
$47.25 - $65.16 $5.2 Million - $7.17 Million
-110,000 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$46.35 - $61.69 $5.56 Million - $7.4 Million
-120,000 Reduced 52.17%
110,000 $6.03 Million
Q2 2020

Aug 14, 2020

BUY
$38.58 - $65.07 $7.91 Million - $13.3 Million
205,000 Added 820.0%
230,000 $13.2 Million
Q2 2019

Aug 13, 2019

BUY
$8.31 - $14.85 $207,750 - $371,250
25,000 New
25,000 $233,000

Others Institutions Holding CCXI

About ChemoCentryx, Inc.


  • Ticker CCXI
  • Exchange NASDAQ
  • Shares Outstandng 71,919,696
  • Market Cap $3.68M
  • Description
  • ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...
More about CCXI
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.